Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3755493
- 101 Pages
- February 2020
- Healthcare
The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Tumor Necrosis Factor (TNF) Inhibitor Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Humira
Enbrel
Remicade
Simponi/Simponi Aria
Cimzia
Biosimilars
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
UCB S.A.
Novartis International AG
Pfizer, Inc.
Merck & co., Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Hidradenitis Suppurativa
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Tumor Necrosis Factor (TNF) Inhibitor Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Tumor Necrosis Factor (TNF) Inhibitor Drugs
1.2.2 Downstream
Table Application Segment of Tumor Necrosis Factor (TNF) Inhibitor Drugs
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market by Type
3.1 By Type
3.1.1 Humira
Table Major Company List of Humira
3.1.2 Enbrel
Table Major Company List of Enbrel
3.1.3 Remicade
Table Major Company List of Remicade
3.1.4 Simponi/Simponi Aria
Table Major Company List of Simponi/Simponi Aria
3.1.5 Cimzia
Table Major Company List of Cimzia
3.1.6 Biosimilars
Table Major Company List of Biosimilars
3.2 Market Size
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Type, in USD Million
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Type, in Volume
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 AbbVie Inc. (Company Profile, Sales Data etc.)
4.1.1 AbbVie Inc. Profile
Table AbbVie Inc. Overview List
4.1.2 AbbVie Inc. Products & Services
4.1.3 AbbVie Inc. Business Operation Conditions
Table Business Operation of AbbVie Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen Inc. (Company Profile, Sales Data etc.)
4.2.1 Amgen Inc. Profile
Table Amgen Inc. Overview List
4.2.2 Amgen Inc. Products & Services
4.2.3 Amgen Inc. Business Operation Conditions
Table Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Johnson & Johnson Services, Inc. (Company Profile, Sales Data etc.)
4.3.1 Johnson & Johnson Services, Inc. Profile
Table Johnson & Johnson Services, Inc. Overview List
4.3.2 Johnson & Johnson Services, Inc. Products & Services
4.3.3 Johnson & Johnson Services, Inc. Business Operation Conditions
Table Business Operation of Johnson & Johnson Services, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 UCB S.A. (Company Profile, Sales Data etc.)
4.4.1 UCB S.A. Profile
Table UCB S.A. Overview List
4.4.2 UCB S.A. Products & Services
4.4.3 UCB S.A. Business Operation Conditions
Table Business Operation of UCB S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Novartis International AG (Company Profile, Sales Data etc.)
4.5.1 Novartis International AG Profile
Table Novartis International AG Overview List
4.5.2 Novartis International AG Products & Services
4.5.3 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Pfizer, Inc. (Company Profile, Sales Data etc.)
4.6.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
4.6.2 Pfizer, Inc. Products & Services
4.6.3 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Merck & co., Inc. (Company Profile, Sales Data etc.)
4.7.1 Merck & co., Inc. Profile
Table Merck & co., Inc. Overview List
4.7.2 Merck & co., Inc. Products & Services
4.7.3 Merck & co., Inc. Business Operation Conditions
Table Business Operation of Merck & co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration, in 2019
Figure Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs MMarket Concentration, in 2019
Figure South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration, in 2019
Figure Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Rheumatoid Arthritis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Rheumatoid Arthritis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Rheumatoid Arthritis, 2015-2019, in Volume
6.1.2 Demand in Psoriasis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Psoriasis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Psoriasis, 2015-2019, in Volume
6.1.3 Demand in Psoriatic Arthritis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Psoriatic Arthritis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Psoriatic Arthritis, 2015-2019, in Volume
6.1.4 Demand in Crohn’s Disease
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Crohn’s Disease, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Crohn’s Disease, 2015-2019, in Volume
6.1.5 Demand in Ulcerative Colitis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Ulcerative Colitis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Ulcerative Colitis, 2015-2019, in Volume
6.1.6 Demand in Ankylosing Spondylitis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Ankylosing Spondylitis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Ankylosing Spondylitis, 2015-2019, in Volume
6.1.7 Demand in Juvenile Idiopathic Arthritis
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Juvenile Idiopathic Arthritis, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Juvenile Idiopathic Arthritis, 2015-2019, in Volume
6.1.8 Demand in Hidradenitis Suppurativa
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Hidradenitis Suppurativa, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Hidradenitis Suppurativa, 2015-2019, in Volume
6.1.9 Demand in Others
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Others, 2015-2019, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share in 2025, by Application, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Growth 2020-2025, by Application, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Production 2015-2019, by Region, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Region, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Region, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Tumor Necrosis Factor (TNF) Inhibitor Drugs
Table Application Segment of Tumor Necrosis Factor (TNF) Inhibitor Drugs
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Enbrel
Table Major Company List of Remicade
Table Major Company List of Simponi/Simponi Aria
Table Major Company List of Cimzia
Table Major Company List of Biosimilars
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Type, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Type, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Type, in Volume
Table AbbVie Inc. Overview List
Table Business Operation of AbbVie Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Inc. Overview List
Table Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Services, Inc. Overview List
Table Business Operation of Johnson & Johnson Services, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table UCB S.A. Overview List
Table Business Operation of UCB S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & co., Inc. Overview List
Table Business Operation of Merck & co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Growth 2020-2025, by Application, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share in 2025, by Application, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Production 2015-2019, by Region, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Production 2015-2019, by Region, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Region, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 2015-2019, by Region, in Volume
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share 2015-2019, by Region, in Volume
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
Table South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2015-2019, by Country, in Volume
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
